Hematologic Malignancies
Conference Coverage
Novel CAR T cells drive high objective response rate in multiple myeloma
CHICAGO – CARs just keep getting better, with a new target for multiple myeloma.
Article
Rituximab Stretches Survival in Follicular Lymphoma
The addition of rituximab has been shown to increase median survival rates among some patients with non-Hodgkin lymphoma.
Conference Coverage
In sickle cell disease, osteomyelitis is a tough call
MONTREAL – How could ESR change osteomyelitis diagnosis in patients with SCD?
News
Chronic Lymphocytic Leukemia in the Real World
Researchers conducted a prospective evaluation of treatment patterns and outcomes for elderly patients with chronic lymphocytic leukemia in a real...
News
Prognostic tool may allow tailored therapy for Hodgkin lymphoma
A newly developed “robust and inexpensive” prognostic tool may allow more tailored therapy for youth with intermediate-risk Hodgkin lymphoma.
News
VA Establishes Presumption of Service Connection for Camp Lejeune
Veterans who served ≥ 30 days at Camp Lejeune and developed 1 of 8 cancer types are eligible for VA reimbursement.
Patient Care
Pretreatment Imaging May Help Prevent Hodgkin Lymphoma Recurrence
Study data reveal pretreatment scanning significantly reduces the risk of relapse and radiation exposure adverse effects in patients with Hodgkin...
News
New approach for monitoring minimum residual disease in multiple myeloma
Next-generation sequencing might be useful to monitor for minimum residual disease in multiple myeloma.
Article
The Link Between Low-Density Lipoproteins and Chronic Lymphocytic Leukemia
Researchers explored the connection of low-density lipoproteins and the development of chronic lymphocytic leukemia.
Original Research
Use of Fluorodeoxyglucose-Positron Emission Tomography in the Diagnosis of Intravascular Diffuse Large B-Cell Lymphoma
Patients with intravascular large B-cell lymphoma often pose a significant diagnostic challenge, particularly in the early stages of the disease,...